GSK Consumer Healthcare Q3 Net up 14% at Rs 147 crore

GlaxoSmithKline (GSK) Consumer Healthcare Ltd reported 14.29% increase in standalone net profit at Rs 146.93 crore for the third quarter ended September 30, aided by higher sales.

The company had reported net profit of Rs 128.55 crore in the same quarter a year ago.

GlaxoSmithKline Consumer Healthcare's net sales went up by 17.44% to Rs 971.94 crore in the September 2013 quarter under review as against Rs 827.54 crore in the corresponding period last year, the company said in a BSE filing.

The company follows January-December as fiscal year.

GSK Consumer Healthcare's advertising and promotion expenses in the quarter were at Rs 163.24 crore, up 20.40% as against Rs 135.58 crore in the same period last year.

Overall expenses of the company in the quarter were at Rs 833.63 crore, an increase of 19.98% as compared with Rs 694.76 crore in the corresponding period last year.

Shares of GlaxoSmithKline Consumer Healthcare were trading at Rs 4,730 apiece in the afternoon trade, up 1.96% from their previous day's close on the BSE.